Recent News

• 02.12.2026 - Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026
• 12.03.2025 - Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference
• 11.21.2025 - Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference
• 11.12.2025 - Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London
• 11.04.2025 - Supernus Announces Third Quarter 2025 Financial Results

Recent Filings

• 02.12.2026 - EX-99.1 EX-99.1
• 02.12.2026 - 8-K Current report
• 02.02.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.28.2026 - 8-K Current report
• 01.21.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.12.2026 - 4 Statement of changes in beneficial ownership of securities
• 12.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.19.2025 - 144 Report of proposed sale of securities
• 12.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities